Literature DB >> 10936621

Tetanus and botulinum neurotoxins: turning bad guys into good by research.

O Rossetto1, M Seveso, P Caccin, G Schiavo, C Montecucco.   

Abstract

The neuroparalytic syndromes of tetanus and botulism are caused by neurotoxins produced by bacteria of the genus Clostridium. They are 150 kDa proteins consisting of three-domains, endowed with different functions: neurospecific binding, membrane translocation and specific proteolysis of three key components of the neuroexocytosis apparatus. After binding to the presynaptic membrane of motoneurons, tetanus neurotoxin (TeNT) is internalized and transported retroaxonally to the spinal cord, where it blocks neurotransmitter release from spinal inhibitory interneurons. In contrast, the seven botulinum neurotoxins (BoNT) act at the periphery and inhibit acetylcholine release from peripheral cholinergic nerve terminals. TeNT and BoNT-B, -D, -F and -G cleave specifically at single but different peptide bonds, VAMP/synaptobrevin, a membrane protein of small synaptic vesicles. BoNT types -A, -C and -E cleave SNAP-25 at different sites within the COOH-terminus, whereas BoNT-C also cleaves syntaxin. BoNTs are increasingly used in medicine for the treatment of human diseases characterized by hyperfunction of cholinergic terminals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 10936621     DOI: 10.1016/s0041-0101(00)00163-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  35 in total

1.  In vitro selection of RNA aptamers that inhibit the activity of type A botulinum neurotoxin.

Authors:  Tzuu-Wang Chang; Michael Blank; Pavithra Janardhanan; Bal Ram Singh; Charlene Mello; Michael Blind; Shuowei Cai
Journal:  Biochem Biophys Res Commun       Date:  2010-05-07       Impact factor: 3.575

2.  Interactions between synaptic vesicle fusion proteins explored by atomic force microscopy.

Authors:  A Yersin; H Hirling; P Steiner; S Magnin; R Regazzi; B Hüni; P Huguenot; P De los Rios; G Dietler; S Catsicas; S Kasas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 3.  Pasteurella multocida toxin as a tool for studying Gq signal transduction.

Authors:  B A Wilson; M Ho
Journal:  Rev Physiol Biochem Pharmacol       Date:  2004-09-29       Impact factor: 5.545

4.  In Vivo Toxicity and Immunological Characterization of Detoxified Recombinant Botulinum Neurotoxin Type A.

Authors:  Easwaran Ravichandran; Pavithra Janardhanan; Kruti Patel; Stephen Riding; Shuowei Cai; Bal Ram Singh
Journal:  Pharm Res       Date:  2015-11-03       Impact factor: 4.200

5.  Differential gene expression and functional analysis implicate novel mechanisms in enteric nervous system precursor migration and neuritogenesis.

Authors:  Bhupinder P S Vohra; Keiji Tsuji; Mayumi Nagashimada; Toshihiro Uesaka; Daniel Wind; Ming Fu; Jennifer Armon; Hideki Enomoto; Robert O Heuckeroth
Journal:  Dev Biol       Date:  2006-06-27       Impact factor: 3.582

Review 6.  Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.

Authors:  Y Bozzi; L Costantin; F Antonucci; M Caleo
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

7.  Vesicle-associated membrane protein (VAMP) cleavage by a new metalloprotease from the Brazilian scorpion Tityus serrulatus.

Authors:  Paul L Fletcher; Maryann D Fletcher; Keith Weninger; Trevor E Anderson; Brian M Martin
Journal:  J Biol Chem       Date:  2009-12-21       Impact factor: 5.157

8.  The identification and biochemical characterization of drug-like compounds that inhibit botulinum neurotoxin serotype A endopeptidase activity.

Authors:  Shuowei Cai; Paul Lindo; Jong-Beak Park; Kruti Vasa; Bal Ram Singh
Journal:  Toxicon       Date:  2009-12-07       Impact factor: 3.033

9.  Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.

Authors:  Maciej Gasior; Rebecca Tang; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2013-06-14       Impact factor: 4.030

10.  Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains.

Authors:  Giovanna Franciosa; Antonella Maugliani; Concetta Scalfaro; Paolo Aureli
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.